Fluorine in pharmaceuticals:: Looking beyond intuition

被引:5507
作者
Mueller, Klaus [1 ]
Faeh, Christoph
Diederich, Francois
机构
[1] F Hoffmann La Roche, Div Pharmaceut, Discovery Chem, CH-4070 Basel, Switzerland
[2] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland
关键词
D O I
10.1126/science.1131943
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents. Organofluorine affects nearly all physical and adsorption, distribution, metabolism, and excretion properties of a lead compound. Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines. In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on molecular conformation of the drug, has only recently begun. Here, we review experimental progress in this vein and add complementary analysis based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.
引用
收藏
页码:1881 / 1886
页数:6
相关论文
共 66 条
  • [1] Discovery of 4-substituted-8-(2-hydroxy-2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of highly selective GlyT1 inhibitors with improved metabolic stability
    Alberati, Daniela
    Hainzl, Dominik
    Jolidon, Synese
    Krafft, Eva A.
    Kurt, Anke
    Maier, Axel
    Pinard, Emmanuel
    Thomas, Andrew W.
    Zimmerli, Daniel
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4311 - 4315
  • [2] Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100
  • [3] Recent advances (1995-2005) in fluorinated pharmaceuticals based on natural products
    Begue, Jean-Pierre
    Bonnet-Delpon, Daniele
    [J]. JOURNAL OF FLUORINE CHEMISTRY, 2006, 127 (08) : 992 - 1012
  • [4] The polar hydrophobicity of fluorinated compounds
    Biffinger, JC
    Kim, HW
    DiMagno, SG
    [J]. CHEMBIOCHEM, 2004, 5 (05) : 622 - 627
  • [5] Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
    Black, WC
    Bayly, CI
    Davis, DE
    Desmarais, S
    Falgueyret, JP
    Léger, S
    Li, CS
    Massé, F
    McKay, DJ
    Palmer, JT
    Percival, MD
    Robichaud, J
    Tsou, N
    Zamboni, R
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4741 - 4744
  • [6] Fluorine in medicinal chemistry
    Böhm, HJ
    Banner, D
    Bendels, S
    Kansy, M
    Kuhn, B
    Müller, K
    Obst-Sander, U
    Stahl, M
    [J]. CHEMBIOCHEM, 2004, 5 (05) : 637 - 643
  • [7] *CAMBR CRYST DAT C, 2007, CSD VERS 5 28
  • [8] *CAMBR CRYST DAT C, 2005, PDB SEARCH PERF US W
  • [9] *DAYL CHEM INF SYS, MEDCHEM DAT VERS 06
  • [10] DELANO WL, 2006, MACPYMOL V0 99